|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 214.46 USD | +1.44% |
|
+0.86% | +9.65% |
| 07-15 | CPC Biotech, Part of PSG and Dover Launches RevolveSD Series One-Inch Single-Use Sterile Disconnect for Bioprocessing | CI |
| 07-10 | Goldman Sachs Adjusts Price Target on Dover to $255 From $263 | MT |
Company Valuation: Dover Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 26,148 | 19,005 | 21,517 | 25,737 | 26,778 | 28,470 | - | - |
| Change | - | -27.32% | 13.21% | 19.62% | 4.04% | 6.32% | - | - |
| Enterprise Value (EV) 1 | 28,887 | 22,303 | 24,561 | 26,822 | 28,429 | 29,586 | 28,902 | 28,373 |
| Change | - | -22.79% | 10.12% | 9.21% | 5.99% | 4.07% | -2.31% | -1.83% |
| P/E | 23.5x | 18.2x | 20.5x | 9.65x | 24.6x | 23.3x | 20.6x | 19x |
| PBR | 6.24x | 4.51x | 4.21x | 3.72x | 3.61x | 3.56x | 3.26x | 3x |
| PEG | - | -4.4x | 15.21x | 0x | -0.4x | 1.6x | 1.6x | 2.22x |
| Capitalization / Revenue | 3.31x | 2.23x | 2.55x | 3.32x | 3.31x | 3.29x | 3.14x | 3x |
| EV / Revenue | 3.65x | 2.62x | 2.91x | 3.46x | 3.51x | 3.42x | 3.19x | 2.99x |
| EV / EBITDA | 17.9x | 13.5x | 13.9x | 16.1x | 15.3x | 14.7x | 13.4x | 12.4x |
| EV / EBIT | 21.9x | 16.6x | 17.2x | 17.6x | 16.7x | 16.1x | 14.7x | 13.2x |
| EV / FCF | 30.6x | 38.1x | 21.5x | 29.1x | 25.4x | 22.8x | 19.6x | 17.6x |
| FCF Yield | 3.27% | 2.62% | 4.66% | 3.43% | 3.93% | 4.39% | 5.11% | 5.68% |
| Dividend per Share 2 | 1.99 | 2.01 | 2.03 | 2.05 | 2.07 | 2.133 | 2.192 | 2.204 |
| Rate of return | 1.1% | 1.48% | 1.32% | 1.09% | 1.06% | 1.01% | 1.04% | 1.04% |
| EPS 2 | 7.74 | 7.42 | 7.52 | 19.45 | 7.94 | 9.069 | 10.26 | 11.13 |
| Distribution rate | 25.7% | 27.1% | 27% | 10.5% | 26.1% | 23.5% | 21.4% | 19.8% |
| Net sales 1 | 7,907 | 8,508 | 8,438 | 7,746 | 8,093 | 8,649 | 9,059 | 9,477 |
| EBITDA 1 | 1,610 | 1,648 | 1,765 | 1,670 | 1,861 | 2,006 | 2,150 | 2,279 |
| EBIT 1 | 1,320 | 1,340 | 1,430 | 1,524 | 1,703 | 1,832 | 1,964 | 2,154 |
| Net income 1 | 1,124 | 1,065 | 1,057 | 2,697 | 1,094 | 1,231 | 1,369 | 1,463 |
| Net Debt 1 | 2,739 | 3,297 | 3,044 | 1,085 | 1,651 | 1,116 | 431.4 | -97.41 |
| Reference price 2 | 181.60 | 135.41 | 153.81 | 187.60 | 195.24 | 211.42 | 211.42 | 211.42 |
| Nbr of stocks (in thousands) | 143,985 | 140,354 | 139,890 | 137,192 | 137,153 | 134,661 | - | - |
| Announcement Date | 1/27/22 | 1/31/23 | 2/1/24 | 1/30/25 | 1/29/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 23.31x | 3.42x | 14.75x | 1.01% | 28.47B | |
| 35.25x | 6.05x | 22.47x | 0.76% | 121B | |
| 31.67x | 5.86x | 20.28x | 1.91% | 38.8B | |
| 33.78x | 4.32x | 15.95x | 0.11% | 31.66B | |
| 21.3x | 1.76x | 12.94x | 2.28% | 30.28B | |
| 25.57x | 3.08x | 13.42x | 1.49% | 27.81B | |
| 24.33x | 3.8x | 12.76x | 1.5% | 27.18B | |
| 110.05x | 38.07x | 89.27x | 0.35% | 25.89B | |
| 26.71x | 3.38x | 16.39x | 1.67% | 24.09B | |
| 93.1x | 6.4x | 33.66x | - | 22.78B | |
| Average | 42.51x | 7.61x | 25.19x | 1.23% | 37.8B | |
| Weighted average by Cap. | 39.31x | 7.01x | 23.85x | 1.12% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- DOV Stock
- Valuation Dover Corporation
Select your edition
All financial news and data tailored to specific country editions
